In addition, RT‒qPCR, western blot, and IHC revealed that PGRN mRNA and protein levels were increased in both the COPD cell model (2% CSE treatment) and patient samples, suggesting a close association between PGRN and COPD (Fig. 4J–L; S4A). This evidence concerns the gene GRN and chronic obstructive pulmonary disease.